Fennec Pharmaceuticals Inc. Insider Trading

FENC

Last 12 months

Insiders sold $1.88M and bought nothing on the open market.

92% of the selling was scheduled in advance under 10b5-1 plans. Chief Medical Officer Pierre Sargis Sayad sold 146K on Aug 31, 56% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2025.

Net open-market

−$1.88M

0 buys · 12 sales

Under a 10b5-1 plan

92%

of the value sold

Insiders who bought / sold

0 / 5

executives and directors

Last open-market buy

May 2025

May 19, 2025

Get an email when FENC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 15	Marco Maria Brughera Director	Sold10b5-1 plan	15,545	$10.29	160K	100%	Form 4
Sep 1	Rosty Raykov Other	Sold10b5-1 plan	10,000	$12.11	121K	7.4%	Form 4
Aug 31	Pierre Sargis Sayad Chief Medical Officer	SoldNo plan	12,000	$12.18	146K	56%	Form 4
Aug 27	Robert Andrade Chief Financial Officer	Sold10b5-1 plan	75,000	$11.78	884K	24%	Form 4
Aug 3	Rosty Raykov Other	Sold10b5-1 plan	10,000	$9.58	96K	7.1%	Form 4
Jul 1	Rosty Raykov Other	Sold10b5-1 plan	9,599	$10.41	100K	6.5%	Form 4
Jun 1	Rosty Raykov Director	Sold10b5-1 plan	9,747	$9.62	94K	7.0%	Form 4
May 11	Chris A Rallis Director	Sold10b5-1 plan	8,346	$7.04	59K	12%	Form 4
May 1	Rosty Raykov Director	Sold10b5-1 plan	10,781	$6.47	70K	8.2%	Form 4
Apr 1	Rosty Raykov Director	Sold10b5-1 plan	10,946	$6.31	69K	8.8%	Form 4
Mar 2	Rosty Raykov Director	Sold10b5-1 plan	10,079	$8.36	84K	8.4%	Form 4
Feb 2	Rosty Raykov Director	Sold10b5-1 plan	10,349	$7.76	80K	9.5%	Form 4
Jan 2	Rosty Raykov Director	Sold10b5-1 plan	10,312	$7.60	78K	10%	Form 4
Dec 24, 2025	Southpoint Capital Advisors LP Large holder	SoldNo plan	1,000,000	$7.50	$7.5M	27%	Form 4
Dec 5, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$7.54	75K	11%	Form 4
Nov 18, 2025	Southpoint Capital Advisors LLC Large holder	SoldNo plan	19,341	$8.79	170K	0.5%	Form 4
Nov 14, 2025 – Nov 17, 2025	Southpoint GP, LLC Large holder	SoldNo plan 2 parts	246,018	$8.28 average	$2.04M	6.1%	Form 4
Nov 5, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$8.10	81K	11%	Form 4
Oct 10, 2025	Chris A Rallis Director	Sold10b5-1 plan	1,775	$9.24	16K	3.0%	Form 4
Oct 7, 2025 – Oct 9, 2025	Southpoint Capital Advisors LLC Large holder	SoldNo plan 3 parts	67,114	$9.48 average	636K	1.6%	Form 4
Oct 6, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$9.78	98K	11%	Form 4
Sep 4, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$8.92	89K	16%	Form 4
Aug 5, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$8.09	81K	15%	Form 4
Jul 7, 2025	Chris A Rallis Director	Sold10b5-1 plan	1,119	$8.71	10K	2.0%	Form 4
Jul 3, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$8.61	86K	14%	Form 4
Jun 5, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$7.78	78K	13%	Form 4
May 16, 2025 – May 19, 2025	Jeffrey S. Hackman Chief Executive Officer	Bought 2 parts	15,000	$6.97 average	105K	New	Form 4
May 16, 2025	Rosty Raykov Director	SoldNo plan	16,667	$6.78	113K	19%	Form 4
May 5, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$6.31	63K	16%	Form 4
Apr 11, 2025	Chris A Rallis Director	Sold10b5-1 plan	1,409	$4.95	7K	2.6%	Form 4
Apr 4, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$5.25	53K	14%	Form 4
Mar 5, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$6.79	68K	13%	Form 4
Feb 14, 2025	Chris A Rallis Director	Sold10b5-1 plan	1,186	$6.82	8K	2.2%	Form 4
Feb 5, 2025	Rosty Raykov Director	Sold10b5-1 plan	10,000	$6.66	67K	12%	Form 4
Jan 6, 2025	Rosty Raykov Director	Sold10b5-1 plan 2 parts	10,000	$6.08 average	61K	11%	Form 4
Dec 5, 2024	Rosty Raykov Director	Sold10b5-1 plan	796	$6.04	5K	1.2%	Form 4
Dec 3, 2024	Rosty Raykov Director	Sold10b5-1 plan	1,635	$6.13	10K	2.4%	Form 4
Dec 2, 2024	Chris A Rallis Director	Sold10b5-1 plan	6,409	$6.14	39K	11%	Form 4

Sep 1510b5-1 plan
Marco Maria Brughera
Director · sold 15,545 at $10.29
160K
100% of stake
Sep 110b5-1 plan
Rosty Raykov
Other · sold 10,000 at $12.11
121K
7.4% of stake
Aug 31No plan
Pierre Sargis Sayad
Chief Medical Officer · sold 12,000 at $12.18
146K
56% of stake
Aug 2710b5-1 plan
Robert Andrade
Chief Financial Officer · sold 75,000 at $11.78
884K
24% of stake
Aug 310b5-1 plan
Rosty Raykov
Other · sold 10,000 at $9.58
96K
7.1% of stake
Jul 110b5-1 plan
Rosty Raykov
Other · sold 9,599 at $10.41
100K
6.5% of stake
Jun 110b5-1 plan
Rosty Raykov
Director · sold 9,747 at $9.62
94K
7.0% of stake
May 1110b5-1 plan
Chris A Rallis
Director · sold 8,346 at $7.04
59K
12% of stake
May 110b5-1 plan
Rosty Raykov
Director · sold 10,781 at $6.47
70K
8.2% of stake
Apr 110b5-1 plan
Rosty Raykov
Director · sold 10,946 at $6.31
69K
8.8% of stake
Mar 210b5-1 plan
Rosty Raykov
Director · sold 10,079 at $8.36
84K
8.4% of stake
Feb 210b5-1 plan
Rosty Raykov
Director · sold 10,349 at $7.76
80K
9.5% of stake
Jan 210b5-1 plan
Rosty Raykov
Director · sold 10,312 at $7.60
78K
10% of stake
Dec 24, 2025No plan
Southpoint Capital Advisors LP
Large holder · sold 1,000,000 at $7.50
$7.5M
27% of stake
Dec 5, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $7.54
75K
11% of stake
Nov 18, 2025No plan
Southpoint Capital Advisors LLC
Large holder · sold 19,341 at $8.79
170K
0.5% of stake
Nov 14, 2025 – Nov 17, 2025No plan
Southpoint GP, LLC
Large holder · sold 246,018 at avg $8.28
$2.04M
6.1% of stake
Nov 5, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $8.10
81K
11% of stake
Oct 10, 202510b5-1 plan
Chris A Rallis
Director · sold 1,775 at $9.24
16K
3.0% of stake
Oct 7, 2025 – Oct 9, 2025No plan
Southpoint Capital Advisors LLC
Large holder · sold 67,114 at avg $9.48
636K
1.6% of stake
Oct 6, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $9.78
98K
11% of stake
Sep 4, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $8.92
89K
16% of stake
Aug 5, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $8.09
81K
15% of stake
Jul 7, 202510b5-1 plan
Chris A Rallis
Director · sold 1,119 at $8.71
10K
2.0% of stake
Jul 3, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $8.61
86K
14% of stake
Jun 5, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $7.78
78K
13% of stake
May 16, 2025 – May 19, 2025
Jeffrey S. Hackman
Chief Executive Officer · bought 15,000 at avg $6.97
105K
New position
May 16, 2025No plan
Rosty Raykov
Director · sold 16,667 at $6.78
113K
19% of stake
May 5, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $6.31
63K
16% of stake
Apr 11, 202510b5-1 plan
Chris A Rallis
Director · sold 1,409 at $4.95
7K
2.6% of stake
Apr 4, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $5.25
53K
14% of stake
Mar 5, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $6.79
68K
13% of stake
Feb 14, 202510b5-1 plan
Chris A Rallis
Director · sold 1,186 at $6.82
8K
2.2% of stake
Feb 5, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at $6.66
67K
12% of stake
Jan 6, 202510b5-1 plan
Rosty Raykov
Director · sold 10,000 at avg $6.08
61K
11% of stake
Dec 5, 202410b5-1 plan
Rosty Raykov
Director · sold 796 at $6.04
5K
1.2% of stake
Dec 3, 202410b5-1 plan
Rosty Raykov
Director · sold 1,635 at $6.13
10K
2.4% of stake
Dec 2, 202410b5-1 plan
Chris A Rallis
Director · sold 6,409 at $6.14
39K
11% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch FENC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with FENC

CompareIntrinsic value

IVVDInvivyd Inc.

$0.63+8.93%10

CSBRChampions Oncology, Inc.

$4.83+0.00%26

RXRXRecursion Pharmaceuticals, Inc.

$3.88+5.43%25

CHRSCoherus Biosciences Inc.

$0.85+5.46%10

EDITEditas Medicine Inc.

$2.73+5.00%40

STROSutro Biopharma, Inc.

$9.94+4.52%10

CGENCompugen Ltd.

$2.03+1.00%75

DTILPrecision Biosciences Inc.

$7.89+13.20%48

Held by ETFs

FENC is in 5 US ETFs. The largest of them, with FENC's weight in each:

Spot a number that looks wrong? Check it in FENC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing FENC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.